GlassScriptPhysician profile
Richard G Sherry
NPI 1538163985
$778.86
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $579 · 2020: $200.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $180.04 | 2019-2020 | |
| Lilly USA, LLC | $79.40 | 2019 | |
| Supernus Pharmaceuticals, INC. | $67.71 | 2019 | |
| Novartis Pharmaceuticals Corporation | $51.43 | 2019-2020 | |
| Amgen INC. | $50.21 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $49.45 | 2019 | |
| Biogen, INC. | $46.18 | 2019-2020 | |
| Tanabe Pharma America, INC. | $46.03 | 2019-2020 | |
| Livanova USA, INC. | $36.14 | 2019 | |
| Csl Behring | $31.08 | 2019-2020 | |
| Strongbridge US INC. | $27.04 | 2020 | |
| Akcea Therapeutics, INC. | $24.45 | 2019 | |
| Genzyme Corporation | $22.48 | 2020 | |
| Amneal Pharmaceuticals LLC | $19.91 | 2019 | |
| Merz North America, INC. | $19.03 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acorda Therapeutics, INC | $16.44 | 2019 | |
| Acadia Pharmaceuticals INC | $11.84 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Sherry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.